Analysts Offer Insights on Healthcare Companies: Pacific Biosciences (PACB), Immunovant (IMVT) and 4D Molecular Therapeutics (FDMT)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pacific Biosciences (PACB – Research ...
ETF Daily News1mon
Pacific Biosciences of California (NASDAQ:PACB) Raised to “Sell” at StockNews.com
PACB stock opened at $2.10 on Thursday. Pacific Biosciences of California has a one year low of $1.16 and a one year high of $7.85. The firm has a market cap of $575.11 million, a price-to ...